Table 3.
Funding source and efficacy outcome of study randomized controlled trials (RCTs).*
| Funding source | RCTs with positive outcome | Total number of RCTs | % RCTs with positive outcome |
|---|---|---|---|
| Industry | 37 | 49 | 75.5 |
| Non-profit | 11 | 16 | 68.8 |
| Mixed | 2 | 5 | 40 |
| Unspecified | 13 | 16 | 81.2 |
86/103 (83.5%) RCTs could be assessed for efficacy outcome.